C-Max Pharmaceuticals Private Limited
About C-Max Pharmaceuticals Private Limited
Data last updated:
C-Max Pharmaceuticals Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the retail trade segment of the home appliances and consumer durables sector. It was incorporated on 29 October 2010.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U52310MH2010PTC209610.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Max Cure Pharma Chem Private Limited. It was led by directors Khan Gufran and Parvezahmad Sekhbaboo Farooqui.
Its last annual general meeting (AGM) was held on 30 September 2013, and its latest financial statements are for the year ended 31 March 2013. The registered office was at 106 B Wing Thevar Apartment Sion Mumbai Link Road Sarvi, Maharashtra, India – 400017.
Company details
Contact details
C-Max Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address106 B Wing Thevar Apartment Sion Mumbai Link Road Sarvi, Maharashtra, India – 400017
- IndustryHome Appliances, Retailers, Specialized Stores
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of C-Max Pharmaceuticals Private Limited
FY 2013 filings availableFinancial Statement Summary
| Metrics | FY 2012-13 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2012-13 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of C-Max Pharmaceuticals Private Limited, buy the company report.
Board of directors of C-Max Pharmaceuticals Private Limited
C-Max Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Khan Gufran | Director | 29 Oct 2010 | 15 Years 11 Months | As last reported |
| Parvezahmad Sekhbaboo Farooqui | Director | 29 Oct 2010 | 15 Years 11 Months | As last reported |
Legal cases
No court or tribunal cases involving C-Max Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for C-Max Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for C-Max Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
C-Max Pharmaceuticals Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Khan Gufran was appointed as Director on 29 Oct 2010.
Frequently asked questions
C-Max Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
C-Max Pharmaceuticals was a private limited company based in Mumbai, Maharashtra, India. The company worked in retailers, within the home appliances industry. It was incorporated on 29 October 2010 and is registered under CIN U52310MH2010PTC209610. The company has been struck off by the Registrar of Companies and is no longer operational.
C-Max Pharmaceuticals had 2 directors:
- Khan Gufran - Director
- Parvezahmad Sekhbaboo Farooqui - Director
The CIN (Corporate Identification Number) of C-Max Pharmaceuticals is U52310MH2010PTC209610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of C-Max Pharmaceuticals is at 106 B Wing Thevar Apartment Sion Mumbai Link Road Sarvi, Maharashtra, India – 400017.
C-Max Pharmaceuticals was incorporated on 29 October 2010. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of C-Max Pharmaceuticals on record with the MCA are for the year ended 31 March 2013. Its last annual general meeting was held on 30 September 2013. Year-wise statements from 2015 are in the company report.
C-Max Pharmaceuticals operated in the home appliances industry, in the retailers segment. It worked in this industry before it was struck off.
Khan Gufran was appointed as Director on 29 Oct 2010. Parvezahmad Sekhbaboo Farooqui was appointed as Director on 29 Oct 2010.
Yes. C-Max Pharmaceuticals was formerly known as Max Cure Pharma Chem Private Limited.